Therefore, the likelihood of potentially including IDH-mutant gliomas among RANO classes 2–4 is very low and no potential IDH-mutant patient are in the RANO class 1 (supramaximal resection) resected patient groups from the studies by Tropeano et al. [11] and Park et al. [13]. Here, IDH1 is linked to central nervous system cancer.